×
About 58,348 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  18,241 results

Necrotizing Fasciitis In A Patient with Metastatic Clear Cell Ovarian Carcinoma Treated...
https://doi.org/10.12659/AJCR.935584
The American Journal of Case Reports; Haider A, Gurjar H et. al.

Jun 26th, 2022 - BACKGROUND Necrotizing fasciitis is a life-threatening infection of the deep soft tissues that leads to progressive destruction of the fascia and subcutaneous fat. It typically spreads along the muscle fascia planes because of the relatively poor ...

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver ...
https://doi.org/10.1016/j.jhep.2022.06.012
Journal of Hepatology; Peiseler M, Schwabe R et. al.

Jun 25th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease and emerging as the leading cause of liver cirrhosis, liver transplantation and hepatocellular carcinoma (HCC). NAFLD is a metabolic disease and considered the he...

HBV seroprevalence and liver fibrosis status among population born before national immu...
https://doi.org/10.1371/journal.pone.0270458
PloS One; Sono S, Sae-Chan J et. al.

Jun 25th, 2022 - Hepatitis B virus (HBV) infection is the leading cause of liver-related death worldwide, particularly in Asia. Patients with either current or past HBV infection are at risk of cirrhosis and hepatocellular carcinoma (HCC). Here, we investigated th...

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Random...
https://doi.org/10.1016/j.cgh.2022.05.042
Clinical Gastroenterology and Hepatology : the Official C... Bajaj JS, Hassanein TI et. al.

Jun 25th, 2022 - Cirrhosis-related complications are a major burden. Rifaximin soluble solid dispersion (SSD) tablets (immediate-release [IR]; sustained extended-release [SER]) were designed to increase rifaximin water solubility. These analyses evaluate dosing fo...

Targeted antiviral treatment of hepatitis B virus in culturally and linguistically dive...
https://doi.org/10.1111/jvh.13727
Journal of Viral Hepatitis; Taye BW, Valery PC et. al.

Jun 25th, 2022 - The majority of Australia's hepatitis B virus (HBV) burden is borne by culturally and linguistically diverse (CALD) populations, and antiviral treatment is the mainstay of intervention. Using modelling, we estimated the impact of targeted antivira...

see more →

Guidelines  41 results

EASL Clinical Practice Guidelines on haemochromatosis.
https://doi.org/10.1016/j.jhep.2022.03.033
Journal of Hepatology; ,

Jun 7th, 2022 - Haemochromatosis is characterised by elevated transferrin saturation (TSAT) and progressive iron loading that mainly affects the liver. Early diagnosis and treatment by phlebotomy can prevent cirrhosis, hepatocellular carcinoma, diabetes, arthropa...

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diag...
https://doi.org/10.1016/j.eprac.2022.03.010
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombos...
https://doi.org/10.1016/j.jhep.2021.09.003
Journal of Hepatology; ,

Mar 19th, 2022 - The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including curre...

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients ...
https://doi.org/10.1053/j.gastro.2021.08.015
Gastroenterology O'Shea RS, Davitkov P et. al.

Sep 29th, 2021 - AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.|2021|O'Shea RS,Davitkov P,Ko CW,Rajasekhar A,Su GL,|adverse effects,therapeutic use,drug effects,blood,diagnosis,drug therapy,standards,chemical...

AGA Technical Review on Coagulation in Cirrhosis.
https://doi.org/10.1053/j.gastro.2021.09.004
Gastroenterology Intagliata NM, Davitkov P et. al.

Sep 29th, 2021 - AGA Technical Review on Coagulation in Cirrhosis.|2021|Intagliata NM,Davitkov P,Allen AM,Falck-Ytter YT,Stine JG,|adverse effects,therapeutic use,drug effects,blood,diagnosis,drug therapy,standards,chemically induced,blood,diagnosis,drug therapy,

see more →

Drugs  645 results see all →

Clinicaltrials.gov  2,375 results

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

Jun 24th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Seroprevalence of Hepatitis E in People With an Organ Transplant
https://clinicaltrials.gov/ct2/show/NCT02190253

Jun 24th, 2022 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...

Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
https://clinicaltrials.gov/ct2/show/NCT02400216

Jun 24th, 2022 - Hepatitis C (HCV) is a leading cause of cirrhosis worldwide. Most complications associated with cirrhosis are driven by an altered portal circulation and the development of portal hypertension. Bacterial translocation (BT) from the gut to the syst...

Natural History of Noncirrhotic Portal Hypertension
https://clinicaltrials.gov/ct2/show/NCT02417740

Jun 24th, 2022 - Noncirrhotic Portal Hypertension (NCPH) includes a spectrum of chronic liver diseases characterized by increased pressure within the portal circulation in the absence of cirrhosis. The complications from NCPH are similar to that of cirrhosis induc...

Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
https://clinicaltrials.gov/ct2/show/NCT00326482

Jun 24th, 2022 - At present, there are no clear guidelines as to when antiretroviral therapy for human immunodeficiency virus (HIV) infection should be stopped in the setting of elevated liver enzymes. In large part, this is due to a limited understanding of the n...

see more →

News  1,982 results

Are pain meds the only option for chronic pain in cirrhosis?
https://www.mdedge.com/internalmedicine/article/255747/hepatology/are-pain-meds-only-option-chronic-pain-cirrhosis
Jim Kling

Jun 24th, 2022 - Pain is common in patients with cirrhosis, and its management presents significant challenges to health care providers, such as worries about GI bleeding, renal injury, falls, and hepatic encephalopathy. To address those issues, researchers at the.

HCC with Child-Pugh B cirrhosis: Nivolumab a promising first-line systemic treatment option
https://www.mdedge.com/fedprac/article/255709/hepatocellular-carcinoma/hcc-child-pugh-b-cirrhosis-nivolumab-promising-first

Jun 23rd, 2022 - Key clinical point: Nivolumab may serve as a first-line systemic treatment option in patients with hepatocellular carcinoma (HCC) and Child-Pugh B (CP-B) cirrhosis. Major finding: Patients receiving nivolumab vs.

Alcoholic Cirrhosis Is Most Common Liver Transplant Indication in Young US Adults
https://www.medscape.com/viewarticle/975925

Jun 22nd, 2022 - NEW YORK (Reuters Health) - Alcohol-associated liver disease is now the most common indication for liver transplant wait-listing among young American adults, researchers say. From 2003 to 2018, the diagnosis of alcoholic liver disease (ALD) as an ...

Rippled Macules and Papules on the Legs
https://www.mdedge.com/dermatology/article/255246/mixed-topics/rippled-macules-and-papules-legs
Kieu Oanh Nguyen, MD, Kristopher M. Peters, DO

Jun 7th, 2022 - The Diagnosis: Cutaneous Amyloidosis A punch biopsy confirmed the diagnosis of cutaneous amyloidosis, which is characterized by the deposition of amyloid proteins in the skin without systemic involvement. Subtypes of cutaneous amyloidosis include.

Pseudocirrhosis in breast cancer may signal liver metastases
https://www.mdedge.com/hematology-oncology/article/255240/breast-cancer/pseudocirrhosis-breast-cancer-may-signal-liver
Jim Kling

Jun 7th, 2022 - CHICAGO – In a large case series of metastatic breast cancer patients with pseudocirrhosis, researchers found that almost all such patients had hormone receptor–positive (HR+) disease as well as extensive liver metastases. Pseudocirrhosis appears.

see more →

Patient Education  55 results see all →